174 related articles for article (PubMed ID: 36159165)
1. Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study.
Samsonov D; Zolotnitskaya A; Matloff R; Pereira T; Solomon S
Kidney Med; 2022 Oct; 4(10):100534. PubMed ID: 36159165
[TBL] [Abstract][Full Text] [Related]
2. Early clinical course of biopsy-proven IgA vasculitis nephritis.
Butzer S; Hennies I; Gimpel C; Gellermann J; Schalk G; König S; Büscher AK; Lemke A; Pohl M
BMC Pediatr; 2022 Oct; 22(1):570. PubMed ID: 36195856
[TBL] [Abstract][Full Text] [Related]
3. Half of children with IgA vasculitis-associated nephritis with nephrotic state spontaneously recover.
Deki S; Hamada R; Mikami N; Terano C; Harada R; Hamasaki Y; Ishikura K; Honda M; Hataya H
Nephrology (Carlton); 2022 Aug; 27(8):681-689. PubMed ID: 35362228
[TBL] [Abstract][Full Text] [Related]
4. Outcome of children with IgA vasculitis with nephritis treated with steroids: a matched controlled study.
Mary AL; Clave S; Rousset-Rouviere C; Berard E; Boyer O; Decramer S; Fila M; Guigonis V; Cloarec S; Harambat J; Hogan J; Lahoche A; Roussey-Kesler G; Zaloszyc A; Ulinski T; Parmentier C; Delbet JD
Pediatr Nephrol; 2023 Oct; 38(10):3317-3326. PubMed ID: 37154959
[TBL] [Abstract][Full Text] [Related]
5. Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: A retrospective cohort study.
Kang Z; Xun M; Li Z; Yang Z
Front Pediatr; 2022; 10():959212. PubMed ID: 36340706
[TBL] [Abstract][Full Text] [Related]
6. The scope of treatment of pediatric IgA vasculitis nephritis and its outcome: a Pediatric Nephrology Research Consortium study.
Kallash M; Vogt BA; Zeid A; Khin E; Najjar M; Aldughiem A; Benoit E; Stotter B; Rheault M; Warejko JK; Daga A
Pediatr Nephrol; 2022 Nov; 37(11):2687-2697. PubMed ID: 35233641
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.
Su Q; Liang Y; Wang N; Dou Z; Rong Z; Zhao X; Yu B; Wang Y; Wang X
Turk J Med Sci; 2021 Oct; 51(5):2683-2689. PubMed ID: 34392671
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis.
Nagai S; Horinouchi T; Ninchoji T; Ichikawa Y; Tanaka Y; Kitakado H; Ueda C; Kondo A; Aoto Y; Sakakibara N; Kaito H; Tanaka R; Shima Y; Fujimura J; Kamiyoshi N; Ishimori S; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
Pediatr Nephrol; 2023 Dec; 38(12):4023-4031. PubMed ID: 37380934
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.
Lu Z; Song J; Mao J; Xia Y; Wang C
Med Sci Monit; 2017 May; 23():2333-2339. PubMed ID: 28515415
[TBL] [Abstract][Full Text] [Related]
11. Outcome of immunosuppression in children with IgA vasculitis-related nephritis.
Rohner K; Marlais M; Ahn YH; Ali A; Alsharief A; Novak AB; Brambilla M; Cakici EK; Candan C; Canpolat N; Yu-Hin Chan E; Decramer S; Didsbury M; Durao F; Durkan AM; Düzova A; Forbes T; Gracchi V; Güngör T; Horinouchi T; Demir BK; Kobayashi Y; Koskela M; Kurt-Sukur ED; La Scola C; Langan D; Li X; Malgieri G; Mastrangelo A; Min J; Mizerska-Wasiak M; Moussaoui N; Noyan A; Nuutinen M; O'Gormon J; Okamoto T; Oni L; Oosterveld M; Pańczyk-Tomaszewska M; Parmaksiz G; Pasini A; Rianthavorn P; Roelofs J; Shen Y; Sinha R; Topaloglu R; Torres DD; Udagawa T; Wennerström M; Yap YC; Tullus K
Nephrol Dial Transplant; 2024 Jan; ():. PubMed ID: 38211969
[TBL] [Abstract][Full Text] [Related]
12. The Outcome of Childhood Immunoglobulin A Nephropathy with Acute Kidney Injury at the Onset of the Disease-National Study.
Mizerska-Wasiak M; Płatos E; Małdyk J; Miklaszewska M; Drożdż D; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Sikora P; Rybi-Szumińska A; Wasilewska A; Szczepańska M; Drożynska-Duklas M; Żurowska A; Pukajło-Marczyk A; Zwolińska D; Tkaczyk M; Pańczyk-Tomaszewska M
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892592
[No Abstract] [Full Text] [Related]
13. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
[TBL] [Abstract][Full Text] [Related]
14. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.
Delbet JD; Geslain G; Auger M; Hogan J; Salomon R; Peuchmaur M; Deschênes G; Buob D; Parmentier C; Ulinski T
Pediatr Nephrol; 2020 Feb; 35(2):313-320. PubMed ID: 31696358
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis.
Wang Y; Wang H; Ma X; Zhu Z; Tian X; Fu R; Jia L
BMC Nephrol; 2024 Jan; 25(1):35. PubMed ID: 38273279
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of tacrolimus in treating refractory IgA vasculitis nephritis: a single-center retrospective study on 16 cases.
Gan Y; Chen J; Wang M; Li Q; Wang A; Yang H
Clin Kidney J; 2024 May; 17(5):sfae115. PubMed ID: 38742208
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
